{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T12:40:02Z","timestamp":1759236002535,"version":"3.44.0"},"reference-count":57,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T00:00:00Z","timestamp":1759190400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T00:00:00Z","timestamp":1759190400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100010661","name":"Horizon 2020 Framework Programme","doi-asserted-by":"publisher","award":["899670","899670","899670","899670","899670","899670","899670","899670","899670","899670","899670","899670","899670"],"award-info":[{"award-number":["899670","899670","899670","899670","899670","899670","899670","899670","899670","899670","899670","899670","899670"]}],"id":[{"id":"10.13039\/100010661","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001871","name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia","doi-asserted-by":"publisher","award":["LA\/P\/0087\/2020","LA\/P\/0087\/2020","LA\/P\/0087\/2020","LA\/P\/0087\/2020","LA\/P\/0087\/2020","LA\/P\/0087\/2020","LA\/P\/0087\/2020"],"award-info":[{"award-number":["LA\/P\/0087\/2020","LA\/P\/0087\/2020","LA\/P\/0087\/2020","LA\/P\/0087\/2020","LA\/P\/0087\/2020","LA\/P\/0087\/2020","LA\/P\/0087\/2020"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]},{"name":"iNOVA4Health Programme in Translational Medicine","award":["04462","04462","04462","04462","04462","04462","04462"],"award-info":[{"award-number":["04462","04462","04462","04462","04462","04462","04462"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Biol Eng"],"DOI":"10.1186\/s13036-025-00558-0","type":"journal-article","created":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T12:08:46Z","timestamp":1759234126000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Streamlined purification of ADDomer nanoparticles for scalable biomanufacturing"],"prefix":"10.1186","volume":"19","author":[{"given":"Raquel","family":"Arinto-Garcia","sequence":"first","affiliation":[]},{"given":"Cl\u00e1udia S.","family":"Paiva","sequence":"additional","affiliation":[]},{"given":"Emerson Bryan","family":"Dilla","sequence":"additional","affiliation":[]},{"given":"Dirk E.","family":"Martens","sequence":"additional","affiliation":[]},{"given":"Justin","family":"Sargunas","sequence":"additional","affiliation":[]},{"given":"Michael","family":"Betenbaugh","sequence":"additional","affiliation":[]},{"given":"Dora","family":"Buzas","sequence":"additional","affiliation":[]},{"given":"Georgia","family":"Balchin","sequence":"additional","affiliation":[]},{"given":"Mafalda","family":"Moleirinho","sequence":"additional","affiliation":[]},{"given":"Rute","family":"Castro","sequence":"additional","affiliation":[]},{"given":"Cristina","family":"Peixoto","sequence":"additional","affiliation":[]},{"given":"Imre","family":"Berger","sequence":"additional","affiliation":[]},{"given":"Christiane","family":"Schaffitzel","sequence":"additional","affiliation":[]},{"given":"Paula M.","family":"Alves","sequence":"additional","affiliation":[]},{"given":"Ant\u00f3nio","family":"Rold\u00e3o","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2025,9,30]]},"reference":[{"key":"558_CR1","doi-asserted-by":"publisher","first-page":"eaaw2853","DOI":"10.1126\/sciadv.aaw2853","volume":"5","author":"C Vragniau","year":"2019","unstructured":"Vragniau C, Bufton JC, Garzoni F, Stermann E, Rabi F, Terrat C, et al. Synthetic self-assembling addomer platform for highly efficient vaccination by genetically encoded multiepitope display. Sci Adv. 2019;5:eaaw2853. https:\/\/doi.org\/10.1126\/sciadv.aaw2853.","journal-title":"Sci Adv"},{"key":"558_CR2","doi-asserted-by":"publisher","first-page":"e46075","DOI":"10.1371\/journal.pone.0046075","volume":"7","author":"E Szolajska","year":"2012","unstructured":"Szolajska E, Burmeister WP, Zochowska M, Nerlo B, Andreev I, Schoehn G, et al. The structural basis for the integrity of adenovirus Ad3 Dodecahedron. PLoS ONE. 2012;7:e46075. https:\/\/doi.org\/10.1371\/journal.pone.0046075.","journal-title":"PLoS ONE"},{"key":"558_CR3","doi-asserted-by":"publisher","first-page":"1913","DOI":"10.1016\/j.ymthe.2022.02.011","volume":"30","author":"C Chevillard","year":"2022","unstructured":"Chevillard C, Amen A, Besson S, Hannani D, Bally I, Dettling V, et al. Elicitation of potent SARS-CoV-2 neutralizing antibody responses through immunization with a versatile adenovirus-inspired multimerization platform. Mol Ther. 2022;30:1913\u201325. https:\/\/doi.org\/10.1016\/j.ymthe.2022.02.011.","journal-title":"Mol Ther"},{"key":"558_CR4","doi-asserted-by":"publisher","first-page":"1810","DOI":"10.3390\/v14081810","volume":"14","author":"C Luo","year":"2022","unstructured":"Luo C, Yan Q, Huang J, Liu J, Li Y, Wu K, et al. Using Self-Assembling addomer platform to display B and T epitopes of type O Foot-and-Mouth disease virus. Viruses. 2022;14:1810. https:\/\/doi.org\/10.3390\/v14081810.","journal-title":"Viruses"},{"key":"558_CR5","doi-asserted-by":"publisher","unstructured":"Buzas D, Bunzel HA, Staufer O, Milodowski EJ, Edmunds GL, Bufton JC et al. Antibodies generated in vitro and in vivo elucidate design of a thermostable addomer COVID-19 nasal nanoparticle vaccine 2023. https:\/\/doi.org\/10.1101\/2023.03.17.533092","DOI":"10.1101\/2023.03.17.533092"},{"key":"558_CR6","doi-asserted-by":"publisher","unstructured":"Buzas D, Sun H, Toelzer C, Yadav SKN, Borucu U, Gautam G et al. Engineering the addobody protein scaffold for generation of high-avidity addomer super-binders 2023. https:\/\/doi.org\/10.1101\/2023.09.09.556966","DOI":"10.1101\/2023.09.09.556966"},{"key":"558_CR7","unstructured":"WHOSnakebite envenoming. September 12th, 2023 https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/snakebite-envenoming"},{"key":"558_CR8","doi-asserted-by":"publisher","first-page":"673","DOI":"10.3390\/toxins15120673","volume":"15","author":"SK Menzies","year":"2023","unstructured":"Menzies SK, Arinto-Garcia R, Amorim FG, Cardoso IA, Abada C, Crasset T, et al. ADDovenom: thermostable Protein-Based addomer nanoparticles as new therapeutics for snakebite envenoming. Toxins. 2023;15:673. https:\/\/doi.org\/10.3390\/toxins15120673.","journal-title":"Toxins"},{"key":"558_CR9","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1007\/s12033-015-9850-9","volume":"57","author":"I Szurgot","year":"2015","unstructured":"Szurgot I, Jedynak M, Podsiadla-Bialoskorska M, Piwowarski J, Szolajska E, Chroboczek J. Adenovirus dodecahedron, a VLP, can be purified by size exclusion chromatography instead of Time-Consuming sucrose density gradient centrifugation. Mol Biotechnol. 2015;57:565\u201373. https:\/\/doi.org\/10.1007\/s12033-015-9850-9.","journal-title":"Mol Biotechnol"},{"key":"558_CR10","doi-asserted-by":"publisher","unstructured":"Bieniossek C, Richmond TJ, Berger I, MultiBac. Multigene Baculovirus-Based eukaryotic protein complex production. CP Protein Sci. 2008;51. https:\/\/doi.org\/10.1002\/0471140864.ps0520s51.","DOI":"10.1002\/0471140864.ps0520s51"},{"key":"558_CR11","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1038\/nbt1095","volume":"23","author":"TA Kost","year":"2005","unstructured":"Kost TA, Condreay JP, Jarvis DL. Baculovirus as versatile vectors for protein expression in insect and mammalian cells. Nat Biotechnol. 2005;23:567\u201375. https:\/\/doi.org\/10.1038\/nbt1095.","journal-title":"Nat Biotechnol"},{"key":"558_CR12","doi-asserted-by":"publisher","first-page":"1172","DOI":"10.1056\/NEJMoa2107659","volume":"385","author":"PT Heath","year":"2021","unstructured":"Heath PT, Galiza EP, Baxter DN, Boffito M, Browne D, Burns F, et al. Safety and efficacy of NVX-CoV2373 Covid-19 vaccine. N Engl J Med. 2021;385:1172\u201383. https:\/\/doi.org\/10.1056\/NEJMoa2107659.","journal-title":"N Engl J Med"},{"key":"558_CR13","doi-asserted-by":"publisher","unstructured":"Tian J-H, Patel N, Haupt R, Zhou H, Weston S, Hammond H, et al. SARS-CoV-2 Spike glycoprotein vaccine candidate NVX-CoV2373 elicits immunogenicity in baboons and protection in mice. Microbiology; 2020. https:\/\/doi.org\/10.1101\/2020.06.29.178509.","DOI":"10.1101\/2020.06.29.178509"},{"key":"558_CR14","doi-asserted-by":"publisher","first-page":"2320","DOI":"10.1056\/NEJMoa2026920","volume":"383","author":"C Keech","year":"2020","unstructured":"Keech C, Albert G, Cho I, Robertson A, Reed P, Neal S, et al. Phase 1\u20132 trial of a SARS-CoV-2 Recombinant Spike protein nanoparticle vaccine. N Engl J Med. 2020;383:2320\u201332. https:\/\/doi.org\/10.1056\/NEJMoa2026920.","journal-title":"N Engl J Med"},{"key":"558_CR15","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1007\/s12325-009-0079-5","volume":"26","author":"TF Schwarz","year":"2009","unstructured":"Schwarz TF. Clinical update of the AS04-Adjuvanted human Papillomavirus-16\/18 cervical cancer vaccine, cervarix\u00ae. Adv Therapy. 2009;26:983\u201398. https:\/\/doi.org\/10.1007\/s12325-009-0079-5.","journal-title":"Adv Therapy"},{"key":"558_CR16","doi-asserted-by":"publisher","first-page":"1247","DOI":"10.1016\/S0140-6736(06)68439-0","volume":"367","author":"DM Harper","year":"2006","unstructured":"Harper DM, Franco EL, Wheeler CM, Moscicki A-B, Romanowski B, Roteli-Martins CM, et al. Sustained efficacy up to 4\u00b75 years of a bivalent L1 virus-like particle vaccine against human papillomavirus types 16 and 18: follow-up from a randomised control trial. Lancet. 2006;367:1247\u201355. https:\/\/doi.org\/10.1016\/S0140-6736(06)68439-0.","journal-title":"Lancet"},{"key":"558_CR17","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1093\/jnci\/93.4.284","volume":"93","author":"CD Harro","year":"2001","unstructured":"Harro CD, Pang Y-YS, Roden RBS, Hildesheim A, Wang Z, Reynolds MJ, et al. Safety and immunogenicity trial in adult volunteers of a human papillomavirus 16 L1 Virus-Like particle vaccine. JNCI J Natl Cancer Inst. 2001;93:284\u201392. https:\/\/doi.org\/10.1093\/jnci\/93.4.284.","journal-title":"JNCI J Natl Cancer Inst"},{"key":"558_CR18","doi-asserted-by":"publisher","first-page":"1645","DOI":"10.1056\/NEJMoa020586","volume":"347","author":"LA Koutsky","year":"2002","unstructured":"Koutsky LA, Ault KA, Wheeler CM, Brown DR, Barr E, Alvarez FB, et al. A controlled trial of a human papillomavirus type 16 vaccine. N Engl J Med. 2002;347:1645\u201351. https:\/\/doi.org\/10.1056\/NEJMoa020586.","journal-title":"N Engl J Med"},{"key":"558_CR19","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1111\/j.1750-2659.2008.00053.x","volume":"2","author":"MMJ Cox","year":"2008","unstructured":"Cox MMJ, Patriarca PA, Treanor J. FluBlok, a Recombinant hemagglutinin influenza vaccine. Influenza Resp Viruses. 2008;2:211\u20139. https:\/\/doi.org\/10.1111\/j.1750-2659.2008.00053.x.","journal-title":"Influenza Resp Viruses"},{"key":"558_CR20","doi-asserted-by":"publisher","first-page":"2176","DOI":"10.1016\/j.vaccine.2005.11.005","volume":"24","author":"K Wang","year":"2006","unstructured":"Wang K, Holtz KM, Anderson K, Chubet R, Mahmoud W, Cox MMJ. Expression and purification of an influenza hemagglutinin\u2014one step closer to a Recombinant protein-based influenza vaccine. Vaccine. 2006;24:2176\u201385. https:\/\/doi.org\/10.1016\/j.vaccine.2005.11.005.","journal-title":"Vaccine"},{"key":"558_CR21","doi-asserted-by":"publisher","first-page":"2845","DOI":"10.1002\/bit.27803","volume":"118","author":"B Carvalho","year":"2021","unstructured":"Carvalho B, Peixoto S, Carrondo CT, Silva MJS. Downstream processing for influenza vaccines and candidates: an update. Biotech Bioeng. 2021;118:2845\u201369. https:\/\/doi.org\/10.1002\/bit.27803.","journal-title":"Biotech Bioeng"},{"key":"558_CR22","doi-asserted-by":"publisher","first-page":"2000019","DOI":"10.1002\/biot.202000019","volume":"16","author":"AS Moreira","year":"2021","unstructured":"Moreira AS, Cavaco DG, Faria TQ, Alves PM, Carrondo MJT, Peixoto C. Advances in lentivirus purification. Biotechnol J. 2021;16:2000019. https:\/\/doi.org\/10.1002\/biot.202000019.","journal-title":"Biotechnol J"},{"key":"558_CR23","doi-asserted-by":"publisher","unstructured":"Sandro Q, Relizani K, Benchaouir R. AAV Production Using Baculovirus Expression Vector System. Viral Vectors for Gene Therapy, vol. 1937, New York, NY: Springer New York; 2019, pp. 91\u20139. https:\/\/doi.org\/10.1007\/978-1-4939-9065-8_5","DOI":"10.1007\/978-1-4939-9065-8_5"},{"key":"558_CR24","doi-asserted-by":"publisher","first-page":"83","DOI":"10.3390\/mi8030083","volume":"8","author":"M Shehadul Islam","year":"2017","unstructured":"Shehadul Islam M, Aryasomayajula A, Selvaganapathy P. A review on macroscale and microscale cell Lysis methods. Micromachines. 2017;8:83. https:\/\/doi.org\/10.3390\/mi8030083.","journal-title":"Micromachines"},{"key":"558_CR25","doi-asserted-by":"publisher","unstructured":"De Carvalho JC, Medeiros ABP, Letti LAJ, Kirnev PCS, Soccol CR. Cell Disruption and Isolation of Intracellular Products. Current Developments in Biotechnology and Bioengineering, Elsevier 2017;807\u201322. https:\/\/doi.org\/10.1016\/B978-0-444-63662-1.00035-X","DOI":"10.1016\/B978-0-444-63662-1.00035-X"},{"key":"558_CR26","unstructured":"Cytiva. Strategies for protein purification handbook, 2021. https:\/\/cdn.cytivalifesciences.com\/api\/public\/content\/digi-16870-pdf"},{"key":"558_CR27","unstructured":"Cytiva. Size Exclusion Chromatography handbook, 2020. https:\/\/cdn.cytivalifesciences.com\/api\/public\/content\/digi-11639-pdf"},{"key":"558_CR28","doi-asserted-by":"publisher","unstructured":"Jungbauer A, Hahn R. Chapter 22 Ion-Exchange Chromatography. Methods in Enzymology, vol. 463, Elsevier. 2009;349\u201371. https:\/\/doi.org\/10.1016\/S0076-6879(09)63022-6","DOI":"10.1016\/S0076-6879(09)63022-6"},{"key":"558_CR29","doi-asserted-by":"publisher","unstructured":"Ullah H. The Role of Ion Exchange Chromatography in Purification and Characterization of Molecules. Ion Exchange Technologies, InTech 2012. https:\/\/doi.org\/10.5772\/52537","DOI":"10.5772\/52537"},{"key":"558_CR30","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.jpba.2015.02.037","volume":"113","author":"S Fekete","year":"2015","unstructured":"Fekete S, Beck A, Veuthey J-L, Guillarme D. Ion-exchange chromatography for the characterization of biopharmaceuticals. J Pharm Biomed Anal. 2015;113:43\u201355. https:\/\/doi.org\/10.1016\/j.jpba.2015.02.037.","journal-title":"J Pharm Biomed Anal"},{"key":"558_CR31","doi-asserted-by":"publisher","first-page":"100034","DOI":"10.1016\/j.jcoa.2022.100034","volume":"2","author":"E Gilardoni","year":"2022","unstructured":"Gilardoni E, Regazzoni L. Liquid phase separation techniques for the characterization of monoclonal antibodies and bioconjugates. J Chromatogr Open. 2022;2:100034. https:\/\/doi.org\/10.1016\/j.jcoa.2022.100034.","journal-title":"J Chromatogr Open"},{"key":"558_CR32","doi-asserted-by":"publisher","unstructured":"McCue JT. Chapter 25 Theory and Use of Hydrophobic Interaction Chromatography in Protein Purification Applications. Methods in Enzymology, vol. 463, Elsevier. 2009;405\u201314. https:\/\/doi.org\/10.1016\/S0076-6879(09)63025-1","DOI":"10.1016\/S0076-6879(09)63025-1"},{"key":"558_CR33","unstructured":"Cytiva. Hydrophobic interaction and reversed phase chromatography handbook, 2022. https:\/\/cdn.cytivalifesciences.com\/api\/public\/content\/7-_H1gO0ikaVp8rY9IKlRg-pdf"},{"key":"558_CR34","unstructured":"Cytiva. Multimodal chromatography handbook, 2021. https:\/\/cdn.cytivalifesciences.com\/api\/public\/content\/digi-16870-pdf"},{"key":"558_CR35","doi-asserted-by":"publisher","unstructured":"Thi Nguyen N-V. Perspective Chapter: Mixed-Mode Chromatography. Analytical Liquid Chromatography - New Perspectives, IntechOpen. 2022. https:\/\/doi.org\/10.5772\/intechopen.104545","DOI":"10.5772\/intechopen.104545"},{"key":"558_CR36","doi-asserted-by":"publisher","first-page":"54","DOI":"10.3390\/membranes7030054","volume":"7","author":"A Hassanvand","year":"2017","unstructured":"Hassanvand A, Wei K, Talebi S, Chen G, Kentish S. The role of ion exchange membranes in membrane capacitive deionisation. Membranes. 2017;7:54. https:\/\/doi.org\/10.3390\/membranes7030054.","journal-title":"Membranes"},{"key":"558_CR37","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.memsci.2007.02.045","volume":"297","author":"R Van Reis","year":"2007","unstructured":"Van Reis R, Zydney A. Bioprocess membrane technology. J Membr Sci. 2007;297:16\u201350. https:\/\/doi.org\/10.1016\/j.memsci.2007.02.045.","journal-title":"J Membr Sci"},{"key":"558_CR38","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1016\/j.jviromet.2013.10.017","volume":"195","author":"A Negrete","year":"2014","unstructured":"Negrete A, Pai A, Shiloach J. Use of Hollow fiber tangential flow filtration for the recovery and concentration of HIV virus-like particles produced in insect cells. J Virol Methods. 2014;195:240\u20136. https:\/\/doi.org\/10.1016\/j.jviromet.2013.10.017.","journal-title":"J Virol Methods"},{"key":"558_CR39","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1002\/bit.25545","volume":"112","author":"P Nestola","year":"2015","unstructured":"Nestola P, Peixoto C, Silva RRJS, Alves PM, Mota JPB, Carrondo MJT. Improved virus purification processes for vaccines and gene therapy. Biotech Bioeng. 2015;112:843\u201357. https:\/\/doi.org\/10.1002\/bit.25545.","journal-title":"Biotech Bioeng"},{"key":"558_CR40","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1080\/14712598.2020.1693541","volume":"20","author":"MG Moleirinho","year":"2020","unstructured":"Moleirinho MG, Silva RJS, Alves PM, Carrondo MJT, Peixoto C. Current challenges in biotherapeutic particles manufacturing. Expert Opin Biol Ther. 2020;20:451\u201365. https:\/\/doi.org\/10.1080\/14712598.2020.1693541.","journal-title":"Expert Opin Biol Ther"},{"key":"558_CR41","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.biotechadv.2015.11.005","volume":"34","author":"L Besnard","year":"2016","unstructured":"Besnard L, Fabre V, Fettig M, Gousseinov E, Kawakami Y, Laroudie N, et al. Clarification of vaccines: an overview of filter based technology trends and best practices. Biotechnol Adv. 2016;34:1\u201313. https:\/\/doi.org\/10.1016\/j.biotechadv.2015.11.005.","journal-title":"Biotechnol Adv"},{"key":"558_CR42","doi-asserted-by":"publisher","unstructured":"Wen P, Ellis E, Pujar RS. N. Vaccine development and manufacturing. 1st ed. Wiley; 2014. https:\/\/doi.org\/10.1002\/9781118870914.","DOI":"10.1002\/9781118870914"},{"key":"558_CR43","doi-asserted-by":"publisher","first-page":"e3375","DOI":"10.1002\/btpr.3375","volume":"39","author":"A Kiesewetter","year":"2023","unstructured":"Kiesewetter A, Gupta A, Heinen-Kreuzig A, Greenhalgh T, Stein A. Improved endotoxin removal using ecofriendly detergents for intensified plasmid capture. Biotechnol Prog. 2023;39:e3375. https:\/\/doi.org\/10.1002\/btpr.3375.","journal-title":"Biotechnol Prog"},{"key":"558_CR44","unstructured":"ECHA - European Chemicals Agency. REACH Annex XIV to regulation (EC) No 1907\/2006 of the European Parliament - Authorization List 2023."},{"key":"558_CR45","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1007\/978-1-0716-3878-1_21","volume-title":"Recombinant protein expression in mammalian cells","author":"M Lebendiker","year":"2024","unstructured":"Lebendiker M. Purification and quality control of Recombinant proteins expressed in mammalian cells: A practical review. In: Hacker DL, editor. Recombinant protein expression in mammalian cells. Volume 2810. New York, NY: Springer US; 2024;329\u201353. https:\/\/doi.org\/10.1007\/978-1-0716-3878-1_21."},{"key":"558_CR46","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/S0021-9673(99)00178-8","volume":"852","author":"A Tre\u0161\u010dec","year":"1999","unstructured":"Tre\u0161\u010dec A, \u0160imi\u0107 M, Branovi\u0107 K, Gebauer B, Benko B. Removal of detergent and solvent from solvent\u2013detergent-treated Immunoglobulins. J Chromatogr A. 1999;852:87\u201391. https:\/\/doi.org\/10.1016\/S0021-9673(99)00178-8.","journal-title":"J Chromatogr A"},{"key":"558_CR47","doi-asserted-by":"publisher","first-page":"2367","DOI":"10.1002\/bit.25327","volume":"111","author":"J Zhu-Shimoni","year":"2014","unstructured":"Zhu-Shimoni J, Yu C, Nishihara J, Wong RM, Gunawan F, Lin M, et al. Host cell protein testing by ELISAs and the use of orthogonal methods. Biotech Bioeng. 2014;111:2367\u201379. https:\/\/doi.org\/10.1002\/bit.25327.","journal-title":"Biotech Bioeng"},{"key":"558_CR48","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1208\/s12248-023-00852-z","volume":"25","author":"K Haltaufderhyde","year":"2023","unstructured":"Haltaufderhyde K, Roberts BJ, Khan S, Terry F, Boyle CM, McAllister M, et al. Immunoinformatic risk assessment of host cell proteins during process development for biologic therapeutics. AAPS J. 2023;25:87. https:\/\/doi.org\/10.1208\/s12248-023-00852-z.","journal-title":"AAPS J"},{"key":"558_CR49","doi-asserted-by":"publisher","first-page":"e55","DOI":"10.1002\/cpz1.55","volume":"1","author":"D Sari-Ak","year":"2021","unstructured":"Sari-Ak D, Bufton J, Gupta K, Garzoni F, Fitzgerald D, Schaffitzel C, et al. VLP\u2010factory\u2122 and addomer \u00a9: Self\u2010assembling Virus\u2010Like particle (VLP) technologies for multiple protein and peptide epitope display. Curr Protocols. 2021;1:e55. https:\/\/doi.org\/10.1002\/cpz1.55.","journal-title":"Curr Protocols"},{"key":"558_CR50","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1016\/j.biotechadv.2006.03.002","volume":"24","author":"C Charcosset","year":"2006","unstructured":"Charcosset C. Membrane processes in biotechnology: an overview. Biotechnol Adv. 2006;24:482\u201392. https:\/\/doi.org\/10.1016\/j.biotechadv.2006.03.002.","journal-title":"Biotechnol Adv"},{"key":"558_CR51","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1002\/bit.27945","volume":"119","author":"CCD Joe","year":"2022","unstructured":"Joe CCD, Jiang J, Linke T, Li Y, Fedosyuk S, Gupta G, et al. Manufacturing a chimpanzee adenovirus-vectored SARS\u2010CoV\u20102 vaccine to Meet global needs. Biotech Bioeng. 2022;119:48\u201358. https:\/\/doi.org\/10.1002\/bit.27945.","journal-title":"Biotech Bioeng"},{"key":"558_CR52","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1002\/jgm.1021","volume":"9","author":"T Rodrigues","year":"2007","unstructured":"Rodrigues T, Carvalho A, Carmo M, Carrondo MJT, Alves PM, Cruz PE. Scaleable purification process for gene therapy retroviral vectors. J Gene Med. 2007;9:233\u201343. https:\/\/doi.org\/10.1002\/jgm.1021.","journal-title":"J Gene Med"},{"key":"558_CR53","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1517\/14712598.2013.779249","volume":"13","author":"MM Segura","year":"2013","unstructured":"Segura MM, Mangion M, Gaillet B, Garnier A. New developments in lentiviral vector design, production and purification. Expert Opin Biol Ther. 2013;13:987\u20131011. https:\/\/doi.org\/10.1517\/14712598.2013.779249.","journal-title":"Expert Opin Biol Ther"},{"key":"558_CR54","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1002\/bit.21139","volume":"97","author":"B Kalbfuss","year":"2007","unstructured":"Kalbfuss B, Genzel Y, Wolff M, Zimmermann A, Morenweiser R, Reichl U. Harvesting and concentration of human influenza A virus produced in serum-free mammalian cell culture for the production of vaccines. Biotech Bioeng. 2007;97:73\u201385. https:\/\/doi.org\/10.1002\/bit.21139.","journal-title":"Biotech Bioeng"},{"key":"558_CR55","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1002\/bit.20599","volume":"92","author":"SR Wickramasinghe","year":"2005","unstructured":"Wickramasinghe SR, Kalbfu\u00df B, Zimmermann A, Thom V, Reichl U. Tangential flow microfiltration and ultrafiltration for human influenza A virus concentration and purification. Biotechnol Bioeng. 2005;92:199\u2013208. https:\/\/doi.org\/10.1002\/bit.20599.","journal-title":"Biotechnol Bioeng"},{"key":"558_CR56","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1089\/hgtb.2012.059","volume":"23","author":"V Bandeira","year":"2012","unstructured":"Bandeira V, Peixoto C, Rodrigues AF, Cruz PE, Alves PM, Coroadinha AS, et al. Downstream processing of lentiviral vectors: releasing bottlenecks. Hum Gene Therapy Methods. 2012;23:255\u201363. https:\/\/doi.org\/10.1089\/hgtb.2012.059.","journal-title":"Hum Gene Therapy Methods"},{"key":"558_CR57","unstructured":"WHO. Good manufacturing practices for sterile pharmaceutical products 2011. https:\/\/www.who.int\/docs\/default-source\/medicines\/norms-and-standards\/guidelines\/production\/trs961-annex6-gmp-sterile-pharmaceutical-products.pdf"}],"container-title":["Journal of Biological Engineering"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13036-025-00558-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13036-025-00558-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13036-025-00558-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T12:08:48Z","timestamp":1759234128000},"score":1,"resource":{"primary":{"URL":"https:\/\/jbioleng.biomedcentral.com\/articles\/10.1186\/s13036-025-00558-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,30]]},"references-count":57,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["558"],"URL":"https:\/\/doi.org\/10.1186\/s13036-025-00558-0","relation":{},"ISSN":["1754-1611"],"issn-type":[{"value":"1754-1611","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,30]]},"assertion":[{"value":"21 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 September 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"85"}}